Pursuit (PRSU) Q1 2026 earnings review
Record Q1 Revenue and a Masterclass in Strategic Pruning
Pursuit delivered a 37% YoY revenue acceleration in its seasonally slow first quarter, shrinking its Adjusted EBITDA loss by 15%. But the real story is portfolio optimization. The company is selling its non-core Flyover business for $78.4M (a 15x EBITDA multiple) to double down on high-return, iconic 'forever assets.' The Tabacón acquisition is already outperforming, anchoring strong yield growth across the board. Armed with a fortress balance sheet (pro-forma net leverage under 1.0x), management aggressively bought back $25.2M in stock while reaffirming full-year guidance. Pursuit is successfully executing its transition into a pure-play destination experiential company.
🐂 Bull Case
Selling Flyover for $78.4M at a 15x multiple is a brilliant capital allocation move. It removes a lower-margin, non-core asset and provides dry powder for Vision 2030 projects that target sub-7x return multiples.
Despite broader macroeconomic concerns around discretionary travel, Pursuit grew same-store attraction ticket yields by 5% and lodging RevPAR by 6% in Q1. Perennial demand for iconic locations continues to isolate the company from typical consumer cycles.
🐻 Bear Case
Management reduced the 2026 Growth Capex guidance range due to a 'shift in expected timing of cash outlays.' In construction and approvals for remote national parks, delays can easily compound and push revenue generation further to the right.
As noted in prior quarters, 2025 benefited from unusually 'near perfect' weather conditions. 2026 faces difficult year-over-year comparisons if typical weather and environmental disruptions (like wildfires) return to the parks.
⚖️ Verdict: 🟢
Bullish. Management is ruthlessly optimizing the portfolio. They are selling non-core assets at premium multiples, buying back their own undervalued stock, and reinvesting organically into irreplaceable assets with high pricing power.
Key Themes
Flyover Sale Solidifies 'Pure-Play' Strategy
Pursuit entered an agreement to sell the Flyover Attractions business to Brogent Technologies for $78.4M. This is a massive strategic win. By offloading a business generating just ~$5.2M in annual EBITDA (implied ~15x multiple), Pursuit sharpens its focus purely on iconic, outdoor sightseeing and hospitality. The divestiture pushes pro forma net leverage below 1x, enabling aggressive capital deployment elsewhere.
Aggressive Capital Returns
Management is capitalizing on its strong balance sheet by buying its own stock. Pursuit repurchased $25.2M of common stock during Q1 (average price $35.40). More importantly, the Board just approved a massive $50M increase to the authorization. This acts as a powerful floor for the stock and shows confidence in the underlying asset valuation.
Tabacón Proves the 'Buy' Strategy
The Tabacón Thermal Resort (acquired July 2025) is outperforming expectations with strong RevPAR and visitor growth. This validates the company's M&A thesis: buying high-quality, counter-seasonal assets in new geographies and optimizing them through the Pursuit operating platform.
Growth Capex Timing Delays
A clear red flag buried in the release: The 2026 growth capex guidance was reduced to $70-$80M (from an implied higher prior figure) due to a 'shift in expected timing of cash outlays as it continues to actively work through approvals and planning.' When dealing with National Parks and iconic protected areas, regulatory approvals can cause severe project bottlenecks, potentially delaying the Vision 2030 EBITDA targets.
Secular Experiential Travel Demand
Macro consumer trends remain highly favorable for Pursuit. Consumers continue to prioritize authentic, experiential travel over material goods. The reaffirmed full-year guidance is explicitly backed by 'sustained demand for experiential travel in iconic destinations and positive booking pace for peak season.'
High Operating Leverage Works Both Ways
Operating expenses (exclusive of D&A) jumped 20.9% to $42.2M in Q1. While this was driven by a 37% revenue increase (positive operating leverage), the business remains highly fixed-cost. Any sudden external shock (wildfires, unexpected weather) during the peak Q3 season could severely compress margins, as costs cannot be cut quickly enough to offset lost visitation.
Weather Normalization Creates Tough Comps
Management has previously acknowledged that 2025 featured exceptionally favorable weather with minimal disruptions. The 2026 operational plan bakes in 'weather normalization,' meaning the company faces structural headwinds in its year-over-year growth comparisons for the peak summer months.
Other KPIs
Accelerating. Up 37.4% YoY from $37.5M. This growth primarily reflects strong demand across the portfolio and the inclusion of Tabacón, providing a much-needed boost to the seasonally slow first quarter.
Reversing. An improvement from a loss of $(17.5)M in 25Q1. The year-over-year improvement was driven by higher revenue and strong margin improvement, supported by Tabacón and continued cost discipline, proving the business can optimize its structural off-season bleed.
Stable. Comprising $35.4M in cash and $134.9M available on the revolver. With the pending $78.4M Flyover cash injection, liquidity is exceptionally strong, fully funding the $70-$80M growth capex pipeline without straining the balance sheet.
Guidance
Stable. Up from $452.4M in FY25. When adjusting to exclude Flyover results from both years, this reflects a highly respectable ~10% underlying organic growth rate.
Accelerating. Represents ~9% growth at the midpoint relative to FY25. However, when adjusting for the Flyover sale, the core portfolio's EBITDA is guided to grow 14%, showcasing excellent operating leverage and margin flow-through.
Decelerating against prior internal expectations, but significantly up vs FY25's $41.6M. The reduction relative to prior 2026 guidance is explicitly due to delays in project approvals and planning, extending the timeline for returns on major organic projects.
Key Questions
Impact of Approval Delays
You noted a shift in the timing of cash outlays for Growth Capex due to approvals and planning. Which specific projects (e.g., Jasper SkyTram, Banff Gondola) are facing delays, and does this threaten the 2028 timeline for outsized organic returns?
Use of Flyover Proceeds
With the $78.4M Flyover sale pushing pro forma net leverage below 1x—well below your 2.0x to 3.5x target—will the immediate priority for this cash be accelerating the new $50M share repurchase program, or are there imminent M&A targets in the pipeline?
Tabacón Organic Growth vs Total Growth
Revenue grew 37% in Q1. Can you disaggregate exactly how much of that growth was organic (same-store ticket/RevPAR increases) versus the inorganic addition of Tabacón?